I-Mab Biopharma v. Inhibrx, Inc. et al
| I-Mab Biopharma |
| Inhibrx, Inc. and Brendan Eckelman |
| 1:2022cv00276 |
| March 1, 2022 |
| US District Court for the District of Delaware |
| Vacant Judgeship (2022) |
| Christopher J Burke |
| Defend Trade Secrets Act (of 2016) |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 25, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 56
DECLARATION re #55 Reply Brief by I-Mab Biopharma. (Raucci, Anthony)
|
|
Filing 55
[SEALED] REPLY BRIEF re #35 MOTION to Expedite Discovery filed by I-Mab Biopharma. (Raucci, Anthony)
|
|
Filing 54
REDACTED VERSION of #48 Answering Brief in Opposition by Brendan Eckelman, Inhibrx, Inc.. (Attachments: #1 Exhibit A)(Rovner, Philip)
|
|
Filing 53
NOTICE of Subpoenas to Tracon Pharmaceuticals, Inc. by I-Mab Biopharma (Raucci, Anthony)
|
|
Filing 52
NOTICE OF SERVICE of (1) Plaintiff I-Mab Biopharma's First Set of Interrogatories to Defendants (Nos. 1-2) and (2) Plaintiff I-Mab Biopharma's First Set of Requests for Production to Defendants (Nos. 1-10) filed by I-Mab Biopharma.(Raucci, Anthony)
|
|
Filing 51
NOTICE to Take Deposition of Dr. Brendan Eckelman on June 3, 2022 filed by I-Mab Biopharma.(Raucci, Anthony)
|
|
Filing 50
RESPONSE to Motion re #39 MOTION to Dismiss for Failure to State a Claim - filed by I-Mab Biopharma. (Smith, Rodger)
|
|
Filing 49
[SEALED] First AMENDED COMPLAINT against Brendan Eckelman, Inhibrx, Inc. - filed by I-Mab Biopharma. (Attachments: #1 Ex. A)(Smith, Rodger)
|
|
Filing 48
[SEALED] ANSWERING BRIEF in Opposition re #35 MOTION to Expedite Discovery filed by Brendan Eckelman, Inhibrx, Inc..Reply Brief due date per Local Rules is 5/17/2022. (Attachments: #1 Exhibit A)(Rovner, Philip)
|
|
Filing 47
ORAL ORDER: IT IS HEREBY ORDERED at the time called for by Standing Order No. 2022-VAC-1, the parties shall meet and confer regarding the content of a proposed Scheduling Order, and shall submit such a proposed Scheduling Order. The proposed Scheduling Order shall be consistent with Judge Burke's form "Rule 16 Scheduling Order Non-Patent," which can be found on Judge Burke's portion of the District Court's website under the Forms tab: (www.ded.uscourts.gov/judge/magistrate-judge-christopher-j-burke). To the extent that the parties disagree as to portions of the proposed Scheduling Order, they may highlight those disagreements in bolded text in the Order and explain their respective positions in a joint letter, which shall not exceed three (3) single-spaced pages, and shall be filed along with the proposed Scheduling Order. The proposed Scheduling Order shall not contain dates for motions hearings or for a pretrial conference or trial. After receiving these materials, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference. Ordered by Judge Christopher J. Burke on 5/6/2022. (dlb)
|
|
Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: #CJB Standing Order re Copies (dlb)
|
|
REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:#http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (dlb)
|
|
Filing 46
ORAL ORDER: The parties having filed the appropriate form advising the Court that they do not unanimously consent to the jurisdiction of a Magistrate Judge, IT IS HEREBY ORDERED that, until further order of the Court, this case will remain assigned to the VAC (2022) docket. IT IS FURTHER ORDERED that this case is referred to Magistrate Judge Christopher J. Burke solely for the following purposes: (1) to adjudicate discovery (including fact and expert discovery) and protective order disputes; (2) to issue or modify a scheduling order; (3) to review stipulated orders and pro hac vice motions; and (4) to review requests for mediation in cases other than patent and securities cases. Issued by the Clerk of Court on 5/4/22. (ntl)
|
|
Filing 45
VAC Magistrate Non-Consent completed by the parties filed by I-Mab Biopharma. (Smith, Rodger)
|
|
Filing 44
REDACTED VERSION of #40 Opening Brief in Support, of Their Motion to Dismiss by Brendan Eckelman, Inhibrx, Inc.. (Attachments: #1 Exhibit A-B)(Rovner, Philip)
|
|
SO ORDERED re #43 Stipulation and Order to Extend Time (Set Briefing Schedule: re #39 MOTION to Dismiss for Failure to State a Claim - Answering Brief due 5/19/2022. Reply Brief due 6/2/2022; re #35 Motion for Expedited Discovery - response due 5/10/2022). ORDERED by Judge Maryellen Noreika on 4/28/2022. (dlw)
|
|
Filing 43
STIPULATION and [Proposed] Order to Extend Time by Brendan Eckelman, Inhibrx, Inc.. (Rovner, Philip)
|
|
Filing 42
REDACTED VERSION of #37 Declaration - by I-Mab Biopharma. (Smith, Rodger)
|
|
Filing 41
REDACTED VERSION of #36 Opening Brief in Support - by I-Mab Biopharma. (Smith, Rodger)
|
|
Filing 40
[SEALED] OPENING BRIEF in Support re #39 MOTION to Dismiss for Failure to State a Claim filed by Brendan Eckelman, Inhibrx, Inc..Answering Brief/Response due date per Local Rules is 5/5/2022. (Attachments: #1 Exhibit A-B)(Rovner, Philip)
|
|
Filing 39
MOTION to Dismiss for Failure to State a Claim - filed by Brendan Eckelman, Inhibrx, Inc.. (Attachments: #1 Text of Proposed Order)(Rovner, Philip)
|
|
Filing 38
ORDER denying #6 MOTION for Temporary Restraining Order - filed by I-Mab Biopharma. Signed by Judge Richard G. Andrews on 4/19/2022. (etg)
|
|
Filing 37
[SEALED] DECLARATION re #35 MOTION to Expedite Discovery (of Erik B. Fountain) - by I-Mab Biopharma. (Attachments: #1 Exs. 1-4)(Smith, Rodger)
|
|
Filing 36
[SEALED] OPENING BRIEF in Support re #35 MOTION to Expedite Discovery - filed by I-Mab Biopharma.Answering Brief/Response due date per Local Rules is 5/3/2022. (Attachments: #1 Ex. A)(Smith, Rodger)
|
|
Filing 35
MOTION to Expedite Discovery - filed by I-Mab Biopharma. (Smith, Rodger)
|
|
Pro Hac Vice Attorney Timothy Q. Li for I-Mab Biopharma added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
|
|
Pro Hac Vice Attorney Ching-Lee Fukuda and Erik B Fountain for I-Mab Biopharma added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
|
|
Filing 34
REDACTED VERSION of #28 Reply Brief - by I-Mab Biopharma. (Attachments: #1 Ex. 1, #2 Ex. 2)(Smith, Rodger)
|
|
Filing 33
Letter to The Honorable Court from Rodger D. Smith II regarding request that the Court schedule a hearing - re #6 MOTION for Temporary Restraining Order . (Smith, Rodger)
|
|
SO ORDERED, re #27 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiff's Complaint to April 21, 2022 filed by Inhibrx, Inc., Brendan Eckelman. Reset Answer Deadlines: Brendan Eckelman answer due 4/21/2022; Inhibrx, Inc. answer due 4/21/2022. Signed by Judge Richard G. Andrews on 3/31/2022. (etg)
|
|
Filing 32
REDACTED VERSION of #26 Declaration of Miquel Lopez Forastier by Brendan Eckelman, Inhibrx, Inc.. (Rovner, Philip)
|
|
Filing 31
REDACTED VERSION of #25 Declaration of Brendan Eckelman by Brendan Eckelman, Inhibrx, Inc.. (Attachments: #1 Exhibit A-B)(Rovner, Philip)
|
|
Filing 30
REDACTED VERSION of #24 Exhibit to a Document Exhibits A-C by Brendan Eckelman, Inhibrx, Inc.. (Rovner, Philip)
|
|
Filing 29
REDACTED VERSION of #23 Answering Brief in Opposition by Brendan Eckelman, Inhibrx, Inc.. (Rovner, Philip)
|
|
Filing 28
[SEALED] REPLY BRIEF re #6 MOTION for Temporary Restraining Order - filed by I-Mab Biopharma. (Attachments: #1 Ex. 1, #2 Ex. 2)(Smith, Rodger)
|
|
Filing 27
STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiff's Complaint to April 21, 2022 - filed by Brendan Eckelman, Inhibrx, Inc.. (Rovner, Philip)
|
|
Filing 26
[SEALED] DECLARATION re #23 Answering Brief in Opposition Declaration of Miquel Lopez Forastier by Brendan Eckelman, Inhibrx, Inc.. (Rovner, Philip)
|
|
Filing 25
[SEALED] DECLARATION re #23 Answering Brief in Opposition Declaration of Brendan Eckelman by Brendan Eckelman, Inhibrx, Inc.. (Attachments: #1 Exhibit A-B)(Rovner, Philip)
|
|
Filing 24
[SEALED] EXHIBIT re #23 Answering Brief in Opposition Exhibits A-C by Brendan Eckelman, Inhibrx, Inc.. (Rovner, Philip)
|
|
Filing 23
[SEALED] ANSWERING BRIEF in Opposition re #6 MOTION for Temporary Restraining Order filed by Brendan Eckelman, Inhibrx, Inc..Reply Brief due date per Local Rules is 3/30/2022. (Rovner, Philip)
|
|
Filing 22
ORDER re #21 Stipulation. Set Briefing Schedule: re Motion for Temporary Restraining Order ( #6 ): Answering Brief due 3/23/2022, Reply Brief due 3/30/2022. After the motion has been fully briefed, the Court will determine whether a hearing shall be held. Signed by Judge Maryellen Noreika on 3/18/2022. (mdb)
|
|
Filing 21
STIPULATION and [Proposed] Order to Extend Time re Answering Brief, Reply Brief and Oral Argument on [D.I. 6] Motion for Temporary Restraining Order - by I-Mab Biopharma. (Smith, Rodger)
|
|
SO ORDERED re #11 MOTION for Pro Hac Vice Appearance of Attorney Ching-Lee Fukuda, Tai-Heng Cheng, Timothy Q. Li, and Erik B. Fountain filed by I-Mab Biopharma. ORDERED by Judge Maryellen Noreika on 3/17/2022. (dlw)
|
|
Filing 20
VAC Notice, Consent, Non-Consent, Magistrate Referral (ntl)
|
|
Filing 19
ORAL ORDER: This case has been assigned to the District of Delaware's Vacant Judgeship ("VAC"). Detailed information relating to VAC cases may be found in the Court's Announcement of March 3, 2022 and Standing Order No. 2022-VAC-1 (March 9, 2022), which are found on the Court's website. Consistent with the foregoing Announcement and Standing Order, IT IS HEREBY ORDERED that the parties shall file the "Notice of Consent or Absence of Consent to Proceed Before a United States Magistrate Judge," being docketed along with the instant order, no later than sixty (60) days after service of the Complaint on the first defendant that is served. IT IS FURTHER ORDERED that the Notice, Consent, and Referral forms re: U.S. Magistrate Judge jurisdiction, previously docketed in this case, are VACATED. Issued by the Clerk of Court on 03/16/2022. (ntl)
|
|
Filing 18
NOTICE of Appearance by Philip A. Rovner on behalf of All Defendants (Rovner, Philip)
|
|
Case Assigned to Vacant Judgeship (2022). Please include initials of VAC after the case number on all documents filed. (rjb)
|
|
Filing 17
AFFIDAVIT of Service for Summons, Redacted Complaint and related papers served on Dr. Brendan Eckelman on March 4, 2022, filed by I-Mab Biopharma. (Smith, Rodger)
|
|
Filing 16
Return of Service Executed by I-Mab Biopharma. Inhibrx, Inc. served on 3/4/2022, answer due 3/25/2022. (Smith, Rodger)
|
|
Filing 15
REDACTED VERSION of #9 Declaration by I-Mab Biopharma. (Raucci, Anthony)
|
|
Filing 14
REDACTED VERSION of #8 Declaration by I-Mab Biopharma. (Raucci, Anthony)
|
|
Filing 13
REDACTED VERSION of #7 Opening Brief in Support by I-Mab Biopharma. (Raucci, Anthony)
|
|
Filing 12
REDACTED VERSION of #2 Complaint, by I-Mab Biopharma. (Raucci, Anthony)
|
|
Filing 11
MOTION for Pro Hac Vice Appearance of Attorney Ching-Lee Fukuda, Tai-Heng Cheng, Timothy Q. Li, and Erik B. Fountain - filed by I-Mab Biopharma. (Smith, Rodger)
|
|
Filing 10
ORDER granting #1 Motion to Seal. Signed by Judge Colm F. Connolly on 3/2/2022. (apk)
|
|
Remark: Case Submitted for Routine Judicial Assignment. (apk)
|
|
Filing 9
[SEALED] DECLARATION re #6 MOTION for Temporary Restraining Order -- Declaration of Taylor Guo -- by I-Mab Biopharma. (Attachments: #1 Exs. 1-11)(Raucci, Anthony)
|
|
Filing 8
[SEALED] DECLARATION re #6 MOTION for Temporary Restraining Order -- Declaration of Tai-Heng Cheng -- by I-Mab Biopharma. (Attachments: #1 Exs. 1-11)(Raucci, Anthony)
|
|
Filing 7
[SEALED] OPENING BRIEF in Support re #6 MOTION for Temporary Restraining Order - filed by I-Mab Biopharma.Answering Brief/Response due date per Local Rules is 3/15/2022. (Raucci, Anthony)
|
|
Filing 6
MOTION for Temporary Restraining Order - filed by I-Mab Biopharma. (Raucci, Anthony)
|
|
Filing 5
Summons Issued with Magistrate Consent Notice attached as to Brendan Eckelman on 3/1/2022; Inhibrx, Inc. on 3/1/2022. (Attachments: #1 Summons Issued Brendan Eckelman)(apk)
|
|
Filing 4
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C-Bridge Capital GP, Ltd., Corporate Parent Hillhouse Capital Advisors, Ltd. for I-Mab Biopharma filed by I-Mab Biopharma. (apk)
|
|
Filing 3
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
|
|
Filing 2
[SEALED] COMPLAINT filed with Jury Demand against Brendan Eckelman, Inhibrx, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3814634.) - filed by I-Mab Biopharma. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(apk)
|
|
Filing 1
MOTION for Leave to File Complaint and Exhibit A Under Seal - filed by I-Mab Biopharma. (apk)
|
|
Remark: Exit Electronic Copies to Duty Judge (CFC) (apk)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
